Distinctive microRNAs in esophageal tumor: Early diagnosis, prognosis judgment, and tumor treatment

Diseases of the Esophagus

Volumn 26, Issue 3, 2013, Pages 288-298

  Li, S Q ^a   Chen, F J ^a   Cao, X F ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Early diagnosis; Esophageal tumor; MicroRNA; Prognosis judgment; Tumor treatment

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; DOCETAXEL; FLUOROURACIL; MICRORNA;

BARRETT ESOPHAGUS; BIOGENESIS; CANCER GENETICS; CANCER PROGNOSIS; CARCINOGENESIS; EARLY DIAGNOSIS; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS TUMOR; GENE TARGETING; HUMAN; PRIORITY JOURNAL; REVIEW;

CELL TRANSFORMATION, NEOPLASTIC; EARLY DETECTION OF CANCER; ESOPHAGEAL NEOPLASMS; GENETIC THERAPY; HUMANS; MICRORNAS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84875806369     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2012.01346.x     Document Type: Review

References (98)

1. Jemal A, Bray F, Center M M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Raia R, Calin G A. Non-coding RNAs and cancer: microRNAs and beyond. J Nucleic Acids Invest 2011; 2: 27-30.
3. Garzon R, Calin G A, Croce C M. MicroRNAs in cancer. Annu Rev Med 2009; 60: 167-79.
4. Lee Y, Kim M, Han J etal. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004; 23: 4051-60.
5. Borchert G M, Lanier W, Davidson B L. RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 2006; 13: 1097-101.
6. Lee Y, Ahn C, Han J etal. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425: 415-19.
7. Bohnsack M T, Czaplinski K, Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 2004; 10: 185-91.
8. Chendrimada T P, Gregory R I, Kumaraswamy E etal. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005; 436: 740-44.
9. Diederichs S, Haber D A. Dual role for Argonautes in MicroRNA processing and posttranscriptional regulation of MicroRNA expression. Cell 2007; 131: 1097-108.
10. Kim V N. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 2005; 6: 376-85.
11. Kim Y K, Kim V N. Processing of intronic microRNAs. EMBO J 2007; 26: 775-83.
12. Tsuchida A, Ohno S, Wu W etal. Mir-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. Cancer Sci 2011; 102: 2264-71.
13. Lv M, Zhang X, Jia H etal. An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-alpha and cAMP/PKA pathways. Leukemia 2011; doi:10.1038/leu.2011.273.
14. Olive V, Jiang I, He L. Mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 2010; 42: 1348-54.
15. Medina P P, Nolde M, Slack F J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010; 467: 86-90.
16. Liu X, Sempere L F, Ouyang H etal. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 2010; 120: 1298-309.
17. Jiang S, Zhang H W, Lu M H etal. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 2010; 70: 3119-27.
18. Wang C M, Wang Y, Fan C G etal. MiR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma. Biochem Biophys Res Commun 2011; 411: 586-92.
19. Uesugi A, Kozaki K, Tsuruta T etal. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res 2011; 71: 5765-78.
20. Saini S, Yamamura S, Majid S etal. MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res 2011; 71: 6208-19.
21. Nohata N, Hanazawa T, Kikkawa N etal. Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma. Int J Oncol 2011; 39: 1099-107.
22. Nohata N, Hanazawa T, Kikkawa N etal. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). J Hum Genet 2011; 56: 595-601.
23. Fassan M, Volinia S, Palatini J etal. MicroRNA expression profiling in human Barrett's carcinogenesis. Int J Cancer 2011; 129: 1661-70.
24. Bansal A, Lee I H, Hong X etal. Feasibility of MicroRNAs as biomarkers for Barrett's esophagus progression: a pilot cross-sectional, phase 2 biomarker study. Am J Gastroenterol 2011; 106: 1055-63.
25. Dijckmeester W A, Wijnhoven B P, Watson D I etal. MicroRNA-143 and -205 expression in neosquamous esophageal epithelium following Argon plasma ablation of Barrett's esophagus. J Gastrointest Surg 2009; 13: 846-53.
26. Van Baal J, Vleggaar F P, Siersema P D. Are MicroRNA-215 and 199a-5p potentially useful biomarkers in the development of Barrett's esophagus and esophageal adenocarcinoma? Gastroenterology 2009; 136: A304.
27. Wijnhoven B P, Hussey D J, Watson D I, Tsykin A, Smith C M, Michael M Z. MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma. Br J Surg 2010; 97: 853-61.
28. Yang H, Gu J, Wang K K etal. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res 2009; 15: 5744-52.
29. Mathe E A, Giang H N, Bowman E D etal. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 2009; 15: 6192-200.
30. Liu J J, Bloomston M, Dilhoff M, Yearsley M M, Frankel W L. Esophageal adenocarcinomas overexpress microrna-21: a tissue microarray study of 64 cases using in-situ hybridization. Lab Invest 2009; 89: 138A.
31. Qu D, Sureban S M, May R etal. Comparative evaluation of novel putative stem cell markers and tumor suppressor microRNAs in Barrett's esophagus. Gastroenterology 2011; 140: S224.
32. Fassan M, Mescoli C, Volinia S etal. Micrornas are deregulated in Barrett's carcinogenesis. Dig Liver Dis 2010; 42: S146.
33. Ogawa R, Ishiguro H, Kuwabara Y etal. Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med Mol Morphol 2009; 42: 102-9.
34. Harata K, Ishiguro H, Kuwabara Y etal. MicroRNA-34b has an oncogenic role in esophageal squamous cell carcinoma. Oncol Lett 2010; 1: 685-9.
35. Guo Y, Chen Z, Zhang L etal. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008; 68: 26-33.
36. Inoue N, Isomoto H, Matsushima K etal. Down-regulation of microRNA 10a expression in esophageal squamous cell carcinoma cells. Oncol Lett 2010; 1: 527-31.
37. Feber A, Xi L, Luketich J D etal. MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 2008; 135: 255-60.
38. Okumura T, Shimada Y, Osawa S, Sekine S, Moriyama M, Tsukada K. Expression of miRNAs in p75NTR positive esophageal squamous cell carcinoma. Dis Esophagus 2010; 23: 35A.
39. Matsushima K, Isomoto H, Kohno S, Nakao K. MicroRNAs and esophageal squamous cell carcinoma. Digestion 2010; 82: 138-44.
40. Kimura S, Naganuma S, Susuki D etal. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: MiR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep 2010; 23: 1625-33.
41. Wu B L, Xu L Y, Du Z P etal. MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145. World J Gastroenterol 2011; 17: 79-88.
42. Mitchell P S, Parkin R K, Kroh E M etal. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105: 10513-18.
43. Kibel A S. Commentary on circulating microRNAs as stable blood-based markers for cancer detection. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M, Divisions of Human Biology, Clinical Research, and Public Health Services. Urol Oncol Semin Orig Investig 2009; 27: 461.
44. Ng E K O, Chong W W S, Jin H etal. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009; 58: 1375-81.
45. Resnick K E, Alder H, Hagan J P, Richardson D L, Croce C M, Cohn D E. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009; 112: 55-9.
46. Chen X, Hu Z, Wang W etal. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int J Cancer 2011; 130: 1620-8.
47. Liu R, Zhang C, Hu Z etal. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer 2011; 47: 784-91.
48. Zhang C, Wang C, Chen X etal. Expression profile of MicroRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem 2010; 56: 1871-9.
49. Zhang T, Wang Q, Zhao D etal. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. Clin Sci 2011; 121: 437-47.
50. Komatsu S, Ichikawa D, Takeshita H etal. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 2011; 105: 104-11.
51. Yoo N J, Hur S Y, Kim M S, Lee J Y, Lee S H. Immunohistochemical analysis of RNA-induced silencing complex-related proteins AGO2 and TNRC6A in prostate and esophageal cancers. APMIS 2010; 118: 271-6.
52. Sugito N, Ishiguro H, Kuwabara Y etal. RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin Cancer Res 2006; 12: 7322-8.
53. Ye Y, Wang K K, Gu J etal. Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res (Phila) 2008; 1: 460-69.
54. Wang K, Guo H, Hu H etal. A functional variation in pre-microRNA-196a is associated with susceptibility of esophageal squamous cell carcinoma risk in Chinese Han. Biomarkers 2010; 15: 614-18.
55. Guo H, Wang K, Xiong G etal. A functional varient in microRNA-146a is associated with risk of esophageal squamous cell carcinoma in Chinese Han. Fam Cancer 2010; 9: 599-603.
56. Luthra R, Singh R R, Luthra M G etal. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 2008; 27: 6667-78.
57. Hiyoshi Y, Kamohara H, Karashima R etal. MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 2009; 15: 1915-22.
58. Kan T, Meltzer S J. MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma. Curr Opin Pharmacol 2009; 9: 727-32.
59. Kan T, Sato F, Ito T etal. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and bim. Gastroenterology 2009; 136: 1689-700.
60. Lee K H, Goan Y G, Hsiao M etal. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. Exp Cell Res 2009; 315: 2529-38.
61. Maru D M, Singh R R, Hannah C etal. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am J Pathol 2009; 174: 1940-48.
62. Ohashi S, Kalman R A, Natsuizaka M etal. Genetic ablation of the notch signaling promotes TGF-(beta)-induced epithelial-mesenchymal transition involving posttranscriptional regulation of ZEB1 and ZEB2 by MicroRNA-200 family members. Gastroenterology 2009; 136: A54.
63. Fassan M, Pizzi M, Battaglia G etal. Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis. J Clin Pathol 2010; 63: 692-6.
64. Matsuzaki J, Suzuki H, Saito Y etal. Degradation of caudal-related homeobox 2 (Cdx2) is enhanced by bile acid with up regulation of MicroRNA-221/222 in human esophageal cells on the progression of Barrett's esophagus to adenocarcinoma. Gastroenterology 2011; 140: S309.
65. Kano M, Seki N, Kikkawa N etal. MiR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 2010; 127: 2804-14.
66. Ma W J, Lv G D, Tuersun A etal. Role of microRNA-21 and effect on PTEN in Kazakh's esophageal squamous cell carcinoma. Mol Biol Rep 2010; 38: 3253-60.
67. Liu Q, Lv G D, Qin X etal. Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. Mol Biol Rep 2011; doi:10.1007/s11033-011-0854-7.
68. Matsushima K, Isomoto H, Yamaguchi N etal. MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells. J Transl Med 2011; 9: 1-12.
69. Tian Y, Luo A, Cai Y etal. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem 2010; 285: 7986-94.
70. Chen Z L, Zhao X H, Wang J W etal. MicroRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J Biol Chem 2011; 286: 10725-34.
71. Ding D P, Chen Z L, Zhao X L etal. Mir-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression. Carcinogenesis 2011; 32: 1025-32.
72. Garman K S, Anderson B, Zhang X etal. An in vitro and in vivo analysis of MicroRNA in the pathogenesis of Barrett's esophagus. Gastroenterology 2011; 140: S309.
73. Hu Y, Correa A M, Hoque A etal. Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer 2011; 128: 132-43.
74. Ito T, Sato F, Kan T etal. Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer. Int J Cancer 2011; 129: 2134-46.
75. Li S, Li Z, Guo F etal. MiR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma. J Biomed Sci 2011; 18: 24.
76. Liu M, Wang Z, Yang S etal. TNF-(alpha) is a novel target of miR-19a. Int J Oncol 2011; 38: 1013-22.
77. Imanaka Y, Tsuchiya S, Sato F, Shimada Y, Shimizu K, Tsujimoto G. MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma. J Hum Genet 2011; 56: 270-76.
78. Tsuchiya S, Fujiwara T, Sato F etal. MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J Biol Chem 2011; 286: 420-28.
79. Van Baal J W, Vleggaar F P, Siersema P D. The potential role of MicroRNA-145 via targeting bone morphogenetic protein 4 and its signal transduction pathway in the development of Barrett's esophagus. Gastroenterology 2011; 140: S76.
80. Yuan Y, Zeng Z Y, Liu X H etal. MicroRNA-203 inhibits cell proliferation by repressing DeltaNp63 expression in human esophageal squamous cell carcinoma. BMC Cancer 2011; 11: Article Number 57.
81. Hummel R, Watson D I, Smith C etal. Impact of miRNAs on sensitivity to anticancer treatment in sensitive and resistant esophageal squamous cell carcinoma cell lines. Dis Esophagus 2010; 23: 48A-9A.
82. Hamano R, Miyata H, Yamasaki M etal. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway. Clin Cancer Res 2011; 17: 3029-38.
83. Hummel R, Hussey D J, Michael M Z etal. MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma. Ann Surg Oncol 2010; 18: 253-60.
84. Garofalo M, Croce C M. MicroRNAs: master regulators as potential therapeutics in cancer. Annu Rev Pharmacol Toxicol 2011; 51: 25-43.
85. Garzon R, Marcucci G, Croce C M. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010; 9: 775-89.
86. Xu J, Li C X, Li Y S etal. MiRNA-miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features. Nucleic Acids Res 2011; 39: 825-36.
87. Paranjape T, Slack F J, Weidhaas J B. MicroRNAs: tools for cancer diagnostics. Gut 2009; 58: 1546-54.
88. Mori Y, Ishiguro H, Kuwabara Y etal. MicroRNA-21 induces cell proliferation and invasion in esophageal squamous cell carcinoma. Mol Med Report 2009; 2: 235-9.
89. Akagi I, Miyashita M, Ishibashi O etal. Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma. Dis Esophagus 2011; 24: 523-30.
90. Feber A, Xi L, Pennathur A etal. MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma. Ann Thorac Surg 2011; 91: 1523-30.
91. Nguyen G H, Schetter A J, Chou D B etal. Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma. Clin Cancer Res 2010; 16: 5824-34.
92. Hong L, Han Y, Zhang H etal. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann Surg 2010; 251: 1056-63.
93. Ohta M, Mimori K, Fukuyoshi Y etal. Clinical significance of the reduced expression of G protein gamma 7 (GNG7) in oesophageal cancer. Br J Cancer 2008; 98: 410-17.
94. Kurashige J, Iwatsuki M, Hiyoshi Y etal. MicroRNA-21 and -26a are novel markers to predict the sensitivity of chemotherapy to esophageal squamous cell carcinoma. Dis Esophagus 2010; 23: 64A.
95. Zhang H, Li M, Han Y etal. Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig Dis Sci 2010; 55: 2545-51.
96. Vallbohmer D, Grimminger P P, Wandhoefer C etal. The micro-RNA 192 as an effective response prediction factor in the multimodality therapy of locally advanced esophageal cancer. Gastroenterology 2011; 140: S1025.
97. Beitzinger M, Meister G. MicroRNAs: from decay to decoy. Cell 2010; 140: 612-14.
98. Eiring A M, Harb J G, Neviani P etal. MiR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 2010; 140: 652-65.